JP2019513706A5 - - Google Patents

Download PDF

Info

Publication number
JP2019513706A5
JP2019513706A5 JP2018549568A JP2018549568A JP2019513706A5 JP 2019513706 A5 JP2019513706 A5 JP 2019513706A5 JP 2018549568 A JP2018549568 A JP 2018549568A JP 2018549568 A JP2018549568 A JP 2018549568A JP 2019513706 A5 JP2019513706 A5 JP 2019513706A5
Authority
JP
Japan
Prior art keywords
cells
pharmaceutical composition
onapristone
methyl
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018549568A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019513706A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/023256 external-priority patent/WO2017165315A1/en
Publication of JP2019513706A publication Critical patent/JP2019513706A/ja
Publication of JP2019513706A5 publication Critical patent/JP2019513706A5/ja
Pending legal-status Critical Current

Links

JP2018549568A 2016-03-21 2017-03-20 オナプリストン代謝物質組成物及び方法 Pending JP2019513706A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662310944P 2016-03-21 2016-03-21
US62/310,944 2016-03-21
PCT/US2017/023256 WO2017165315A1 (en) 2016-03-21 2017-03-20 Onapristone metabolite compositions and methods

Publications (2)

Publication Number Publication Date
JP2019513706A JP2019513706A (ja) 2019-05-30
JP2019513706A5 true JP2019513706A5 (enExample) 2020-04-30

Family

ID=59848182

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018549568A Pending JP2019513706A (ja) 2016-03-21 2017-03-20 オナプリストン代謝物質組成物及び方法

Country Status (3)

Country Link
US (1) US20170266204A1 (enExample)
JP (1) JP2019513706A (enExample)
WO (1) WO2017165315A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1246653A1 (zh) 2014-11-17 2018-09-14 Context Biopharma Inc. 奥那司酮延长释放组合物和方法
US10308676B2 (en) 2015-09-25 2019-06-04 Context Biopharma Inc. Methods of making onapristone intermediates
EP3389632A4 (en) 2015-12-15 2019-11-06 Context Biopharma Inc. AMORPHIC ONAPRISTON COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
US20180148471A1 (en) 2016-11-30 2018-05-31 Arno Therapeutics, Inc. Methods for onapristone synthesis dehydration and deprotection

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3321826A1 (de) * 1983-06-15 1984-12-20 Schering AG, 1000 Berlin und 4709 Bergkamen 13(alpha)-alkylgonane, deren herstellung und diese enthaltende pharmazeutische praeparate
DE102006054535A1 (de) * 2006-11-15 2008-05-21 Bayer Schering Pharma Aktiengesellschaft Progesteronrezeptorantagonisten
TW201002736A (en) * 2008-04-28 2010-01-16 Repros Therapeutics Inc Compositions and methods for treating progesterone-dependent conditions
US20130029953A1 (en) * 2011-07-28 2013-01-31 Klaus Nickisch Progesterone antagonists
WO2014164861A1 (en) * 2013-03-12 2014-10-09 Arno Therapeutics Onapristone polymorphic forms and methods of use
US9096641B2 (en) * 2013-06-05 2015-08-04 Evestra, Inc. Imidazolyl progesterone antagonists

Similar Documents

Publication Publication Date Title
JP2022180461A5 (enExample)
JP7394974B2 (ja) 酢酸アビラテロンを含む医薬組成物、並びにその製造方法及び使用
TWI455723B (zh) 納曲酮及安非他酮於治療超重或肥胖病患之用途
JP2012521435A5 (enExample)
JP2009539769A5 (enExample)
JP2008530248A5 (enExample)
JP2018184465A5 (enExample)
JP2012515184A (ja) 大腸がんの治療方法
JP2010501576A5 (enExample)
JP2003533485A5 (enExample)
JP2017516802A5 (enExample)
JP2021509395A5 (enExample)
JP2010538066A5 (enExample)
BR112012030641B1 (pt) Usos e composições para terapia farmacêutica oral
JP2019530706A5 (enExample)
JP2015517523A5 (enExample)
JP2018138594A (ja) オナプリストン多形体及び使用方法
RU2014137128A (ru) Способ лечения заболеваний кишечника с присутствием по меньшей мере одного воспалительного компонента
JP2025508421A (ja) セダズリジンの配合製剤
TWI341728B (en) Combinations comprising epothilones and anti-metabolites
CA2563058A1 (en) Supportive treatment of liver disease
JP2019513706A (ja) オナプリストン代謝物質組成物及び方法
JP2010504307A5 (enExample)
JP2022542725A (ja) 化合物又はその薬学的に許容される塩、二量体又は三量体のがん治療用医薬品の調製における応用
US10092589B2 (en) Anti-tumor agent containing anti-tumor platinum complex, and anti-tumor effect enhancer